FIELD: medicine.
SUBSTANCE: invention represents a balanced infusion solution containing sodium, potassium and magnesium chlorides, a solvent and sodium L-arginine succinate of formula: Na+[NH=C(NH2)NH(CH2)3CH(NH2)COOH]+[OOC(CH2)2COO]2-. The ingredients in the solution are found in certain proportions, wt %.
EFFECT: invention provides enhanced detoxification activity, low toxicity and wide range of clinical applications.
11 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MULTICOMPONENT INFUSION SOLUTION OF ELECTROLYTES IN COMBINATION WITH BIOLOGICALLY ACTIVE COMPONENTS FOR INTRAVENOUS ADMINISTRATION | 2022 |
|
RU2796724C1 |
| DISINTOXICATING INFUSION SOLUTION | 2003 |
|
RU2240116C1 |
| METHOD OF ACUTE PANCREATITIS CORRECTION IN RATS USING MONTMORILLONITE-BASED ENTEROSORBENT | 2018 |
|
RU2700920C1 |
| METHOD OF MODELLING CHRONIC TOXIC HEPATOPATHY | 2010 |
|
RU2440621C1 |
| HEPATOPROTECTIVE CHELATE CIS-S,S-COMPLEX OF DICHLORO-DI-1,6-(3,5-DIMETHYLISOXAZOLE-4-YL)-2,5-DITHIOHEXANE OF PALLADIUM (II) | 2015 |
|
RU2612131C1 |
| MEDICATION, REPRESENTING BETULIN BIS-ISONICOTINOATE, DEMONSTRATING ANTI-ULCER, ANTI-INFLAMMATORY AND HEPATOPROTECTIVE ACTIVITY | 2013 |
|
RU2538212C1 |
| ORAL PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATORY GASTROINTESTINAL DISEASES | 2010 |
|
RU2445965C2 |
| METHOD OF TREATMENT OF LIVER STEATOSIS IN CATS | 2013 |
|
RU2527700C1 |
| METHOD OF PREVENTING CHRONIC TOXIC HEPATOPATHY | 2010 |
|
RU2468446C2 |
| (Z)-METHYL-16-(5-OXO-2-PHENYL-OXAZOL-4-ILIDENMETHYL)-15,16-EPOXY-8(17),13(16),14-LABDATRIEN-18-OATE, POSSESSING ANTIOXIDATIVE, HEPATOPROTECTIVE AND HEMOSTIMULATING ACTIVITY | 2007 |
|
RU2353620C1 |
